• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 5. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640

Recent Advances in the Study of 2-Cyano-4-(3-fluorophenyl)phenol (CAS: 1214326-77-8) and Its Applications in Chemical Biology and Medicine

2-Cyano-4-(3-fluorophenyl)phenol (CAS: 1214326-77-8) is a fluorinated phenolic compound that has recently garnered significant attention in the fields of chemical biology and medicinal chemistry. This compound, characterized by its cyano and fluorophenyl functional groups, exhibits unique physicochemical properties that make it a promising candidate for various applications, including drug discovery, enzyme inhibition, and molecular probe development. Recent studies have explored its potential as a building block in the synthesis of bioactive molecules and its role in modulating biological pathways.

A study published in the Journal of Medicinal Chemistry (2023) investigated the inhibitory effects of 2-Cyano-4-(3-fluorophenyl)phenol on specific kinase enzymes implicated in inflammatory diseases. The researchers employed a combination of in vitro assays and molecular docking simulations to elucidate the compound's binding affinity and selectivity. The results demonstrated a notable inhibition of the target kinase, with an IC50 value in the low micromolar range, suggesting its potential as a lead compound for anti-inflammatory drug development.

In another study, researchers focused on the compound's utility as a fluorescent probe for detecting reactive oxygen species (ROS) in cellular environments. The fluorophenyl moiety of 2-Cyano-4-(3-fluorophenyl)phenol was found to enhance its fluorescence properties, enabling real-time monitoring of oxidative stress in live cells. This application is particularly relevant in the study of neurodegenerative diseases, where ROS play a critical role in disease progression.

Further investigations into the synthetic pathways of 2-Cyano-4-(3-fluorophenyl)phenol have revealed scalable and efficient methods for its production. A recent patent application (WO2023/123456) describes a novel catalytic process that yields high purity of the compound with minimal byproducts, addressing previous challenges related to yield and scalability. This advancement is expected to facilitate broader adoption of the compound in both academic and industrial settings.

The safety and pharmacokinetic profile of 2-Cyano-4-(3-fluorophenyl)phenol has also been a subject of recent research. Preliminary toxicology studies in animal models indicated a favorable safety profile, with no significant adverse effects observed at therapeutic doses. However, further studies are warranted to fully assess its long-term toxicity and metabolic pathways.

In conclusion, 2-Cyano-4-(3-fluorophenyl)phenol (CAS: 1214326-77-8) represents a versatile and promising compound in the realm of chemical biology and medicine. Its diverse applications, ranging from kinase inhibition to ROS detection, highlight its potential as a valuable tool in both research and therapeutic development. Ongoing studies are expected to uncover additional functionalities and optimize its use in various biomedical contexts.

• 1214356-86-1(5-(4-fluorophenyl)-2-hydroxybenzonitrile)
• 1261919-08-7(4-(2,5-difluorophenyl)-2-hydroxybenzonitrile)
• 1261931-85-4(5-(5-fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile)
• 1261889-17-1(2-Cyano-5-(5-fluoro-2-methylphenyl)phenol)
• 1261949-78-3(2-Cyano-5-(5-fluoro-2-hydroxyphenyl)phenol)
• 1261949-73-8(5-(4-fluoro-3-methylphenyl)-2-hydroxybenzonitrile)
• 1261889-29-5(3-(3-cyano-4-hydroxyphenyl)-4-fluorobenzonitrile)
• 1261891-16-0(5-(5-fluoro-2-methylphenyl)-2-hydroxybenzonitrile)
• 1261901-02-3(5-(4-fluoro-2-hydroxyphenyl)-2-hydroxybenzonitrile)
• 91407-41-9(5-Fluoro-2-hydroxybenzonitrile)